Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Development of a pharmaceutical care program in progressive stages in geriatric institutions.

Mestres, Conxita; Hernandez, Marta; Agustí, Anna; Puerta, Laura; Llagostera, Blanca; Amorós, Patricia.
BMC Geriatr; 18(1): 316, 2018 12 19.
Artigo em Inglês | MEDLINE | ID: mdl-30567496

BACKGROUND:

To introduce and manage a Pharmaceutical care programs in geriatric care institutions presents difficulties such as reduced pharmacy service staff, complexity of the patients or lack of integration of the pharmacist in the health care team. This work describes the evolution of the implementations of a program of pharmaceutical care centered in drug related problems (DRP) in a group of geriatric institutions of different levels of complexity.

METHODS:

Setting:

Long-term and subacute care hospitals (HSS) and Health care teams attending nursing homes (EARs).

PARTICIPANTS:

Patients attended in HSS and EARs during different periods between 2010 and 2016.

INTERVENTIONS:

The program was developed in different stages, in which pharmacists made interventions of increasing complexity.

RESULTS:

Between 2010 and 2013, the approach was only to improve the prescription of non-appropriate drugs for the elderly, which was reduced from 19 to 14.5%. Subsequent steps included detection of drug-related problems (DRP), systematization of treatment revisions, recording of pharmacist interventions, improvements in the classification of interventions and the creation of a web-based database for recording in a more efficient way. During these years, there was an increase in the number of patients included in pharmaceutical care activities and thus the number of pharmacist interventions (3872 in 2014 vs 5903 in 2016). In 2016, mean age in 2016 83.2 years old. Mean number of medicines/patient 8.4 ± 3.3, and mean interventions/patient 1.62. Degree of acceptance of the interventions by physicians improved (68.6% in 2016 vs 45.5% in 2012), even though there is still much work to do. The Medication Appropriateness Index (MAI) showed that when the interventions were accepted, there was an important improvement. HSS mean MAI values pre-intervention 2.52, post-intervention 0.80. In EARs 5 pre and 1.39 post. In both cases p < 0.0001.

CONCLUSIONS:

Approaching the deployment of activities in a progressive way has made us more efficient and able to confront and solve the problems that have arisen. Even though there has been a very restricted increase in the staff and budget, we are able to implement a DRP detection programme with guaranties of quality.
Selo DaSilva